Company intelligence / Profile preview

Tech Observer

Paramus, New Jersey, United Statestech-observer.com ↗

Ownership: Private
Employees: ~384
Development stage: Other

Overview

Tech Observer provides end-to-end solutions for clinical development including operations management of trials for pharmaceutical and biotech companies. They offer services such as data management and biostatistics to support successful trial execution. No direct clinical results are attributable to the company itself.

Therapeutic areas: OncologyPulmonologyEndocrinologyWomen's HealthImmunologyHematologyOtherPsychiatryDermatologyRheumatologyNeurologyGastroenterologyCardiovascularOphthalmologyNephrologyInfectious Diseases
Industry: Contract Research Organization

Partnerships

Serves >50 pharma/life science clients worldwide

Beyond the preview

Go deeper on Tech Observer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tech Observer.

Explore the full profile